Advertisement AmerisourceBergen completes divestiture of AndersonBrecon - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AmerisourceBergen completes divestiture of AndersonBrecon

AmerisourceBergen has completed the divestiture of AndersonBrecon for $308m in cash to an entity formed by affiliates of an investor group led by Frazier Healthcare.

The entity group that includes affiliates of Greenspring Associates, QIC Global Private Equity, and Thomas McNerney & Partners was formed to acquire the AmerisourceBergen’s contract packaging business.

The completion of the divestiture has no impact on AmerisourceBergen’s financial performance expectations for fiscal 2013, which were updated on 25 April 2013.

AmerisourceBergen provides drug distribution and related services designed to reduce costs and improve patient outcomes.